Remove office-locations
article thumbnail

Takeda Expands R&D, Office Space in New Cambridge Location

BioSpace

Takeda announced it secured 600,000 square feet of research and development and office space in new construction at Cambridge’s Kendall Square.

article thumbnail

Syntegon Group appoints Dr. Peter Hackel as Chief Financial Officer

Pharma Mirror

In his new position, asChief Financial Officer (CFO) Peter Hackel will be responsible for Finance &Controlling, Foreign Trade and IT of Syntegon. followed by Geistlich Pharma AG, The post Syntegon Group appoints Dr. Peter Hackel as Chief Financial Officer appeared first on Pharma Mirror Magazine.

Packaging 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telstar strengthens its activity in Bangladesh and relocates its office in Dhaka

Pharma Mirror

The new office is located in Green Rawshanara Tower (Level – 10) 755, Satmasjid Road, Dhanmondi C/A. The new office is located in Green Rawshanara Tower (Level – 10) 755, Satmasjid Road, Dhanmondi C/A. The company, which has been active over the past 16 years.

article thumbnail

Pfizer Expanding Operations in Fast-Growing Tampa and Restarting Manufacturing in Michigan

BioSpace

Pfizer announced plans to create a professional services office in Tampa, Florida. It will be located in more than 100,000 square feet of office space and believe they will be generating hundreds of new jobs.

article thumbnail

Thermo Fisher becomes founding sponsor of Florida biotech hub

Outsourcing Pharma

The Alachua, Florida location comprises laboratory and office space for biotech businesses.

article thumbnail

Aridis CEO Confident Inhaled Antibody Formulation Will Play a Key Role in Controlling COVID-19

BioSpace

Only a fraction of intravenous antibody treatments will make their way to the lungs of COVID-19 patients, which is where the infection is primarily located. Aridis Chief Executive Officer Vu Truong believes his company has a better solution – an inhaled antibody.

article thumbnail

Video: Global Laboratory Capabilities

Velocity Clinical Research

This includes purpose-built, CLIA-certified lab facilities at all dedicated sites, as well as in-network PBMC processing at 30+ Velocity locations across the U.S. As Nick Spittal, Chief Operations Officer, explains in this video, Velocity is also using these capabilities to enhance patient engagement. and Europe.